Rituximab and Therapeutic Plasma Exchange in Recurrent Focal Segmental Glomerulosclerosis Postkidney Transplantation

BACKGROUNDFocal segmental glomerulosclerosis (FSGS) is a common cause of end stage renal disease (ESRD) with a high rate of recurrence after kidney transplantation. Several factors such as white race, rapid progression, and previous allograft failure due to recurrence were found to be risks of recur...

Full description

Saved in:
Bibliographic Details
Published in:Transplantation 2018-03, Vol.102 (3), p.e115-e120
Main Authors: Alasfar, Sami, Matar, Dany, Montgomery, Robert A., Desai, Niraj, Lonze, Bonnie, Vujjini, Vikas, Estrella, Michelle M., Dieck, John Manllo, Khneizer, Gebran, Sever, Sanja, Reiser, Jochen, Alachkar, Nada
Format: Article
Language:English
Subjects:
Adolescent
Adult
Female
Glomerulosclerosis, Focal Segmental - etiology
Glomerulosclerosis, Focal Segmental - prevention & control
Humans
Kidney Transplantation - adverse effects
Male
Middle Aged
Plasma Exchange
Prospective Studies
Recurrence
Rituximab - therapeutic use
Young Adult
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!